Join SCI and SunGard for a webinar to explore some of the current themes in CVA and counterparty risk.
Panel includes:
Anna Carlisle, Associate Editor, SCI (moderator)
Alan Baxter, UBS
Pawn Malik, Navigant Capital Advisors
Dan Travers, SunGard
(an additional two panellists are to be invited)
Discussions include:
Technology and infrastructure
How prepared are banks to deal with the changes to CVA calculation and the new capital charges under Basel III?
How far does an institution need to go in terms of implementing CVA solutions? Which trades does/should it affect?
Where does CVA fit into the bank’s overall structure?
What are the challenges involved in implementing CVA systems?
What are the larger and more sophisticated institutions doing for CVA technology, and how much should they invest?
What are the options for less sophisticated institutions?
Will cost of infrastructure preclude certain institutions from CVA?
The CVA desk
How can banks price CVA competitively?
How is the role and activity of the CVA desk developing?
Which CVA risk management practices are CVA desks using?
How are hedging strategies for CVA evolving?
How big a challenge will the arbitrage between CVA hedging for internal risk management purposes versus the treatment of CVA hedges for regulatory capital be?
What future does contingent CDS (CCDS) have in relation to counterparty risk management?
Will supply issues of the product (CCDS) be resolved in the near-term?
Strategies for modelling wrong-way risk
CVA as a traded risk
How can CVA be transformed into a traded risk?
How active is this market currently?
How is it likely to develop?
What could be the catalyst for growth/ what could hinder progress?
Looking ahead
What are the next steps for the industry?
What do CVA market participants want/need from regulators?
Are there any potential glitches on the horizon and how can the industry prepare?
Space is limited.
Date: 2nd February 2012
Comments